Idiopathic Intracranial Hypertension (IIH) Post COVID-19 Infection: Case Report

Authors

  • Pradeep Bastola Kathmandu University
  • Sunil Koirala Kathmandu, Narayan Gopal Chowk, Maharajgunj
  • Polina Dahal Associate Professor, Chitwan Medical College, Nepal

Keywords:

Magnetic resonance imaging; pseudotumor cerebri; visual acuity.

Abstract

Pseudotumor cerebri or benign intracranial hypertension (BIH) or idiopathic intracranial hypertension (IIH) is a clinical condition that includes headache, papilledema, increased blood pressure, and clear cerebrospinal fluid. Multiple causes have been described for this condition, including venous sinus thrombosis, the toxicity of some substances such as vitamin A, tetracyclines and oral contraceptives, and sepsis besides patients related factors like obesity and middle-aged females.

We report here a case of pseudotumor cerebri in a 28 years lady presenting to the Department of Ophthalmology, Chitwan Medical College (CMC), Nepal with a history of COVID-19 infection two months earlier. To our knowledge, this is the first report of post-COVID-19 associated isolated benign intracranial hypertension (BIH) from Nepal.

 

Downloads

Published

2022-02-28

How to Cite

1.
Bastola P, Koirala S, Polina Dahal. Idiopathic Intracranial Hypertension (IIH) Post COVID-19 Infection: Case Report: . Journal of Karnali Academy of Health Sciences [Internet]. 2022Feb.28 [cited 2024Apr.27];4(3). Available from: https://jkahs.org.np/jkahs/index.php/jkahs/article/view/554

Issue

Vol. 4 No. 3 (2021): JKAHS; Sep-Dec Issue (12)

Section

Case report

License

Copyright (c) 2022 Pradeep Bastola, Dr. Sunil Koirala, Polina Dahal

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The author(s) retain the copyright and the full publishing right without restriction under the Creative Commons Attribution 4.0 International License (CC BY 4.0) which allows readers to share (copy and redistribute the material in any medium or format) and adapt (remix, transform, and build upon the material) for any purpose, even commercially, provided the work is properly attributed. (https://creativecommons.org/licenses/by/4.0/).

Author(s) grant the non-exclusive publishing right to the Journal of Karnali Academy of Health Sciences (JKAHS). The publishing rights include the rights to publish, reproduce, distribute, include in indexes or search databases or other media in print or online. The JKAHS may require revisions to the manuscript before acceptance for publication or may choose not to publish it based on the judgement of the editors. Further, JKAHS might retract, withdraw, or publish a correction or other notice after publication, if such publication would be inconsistent with the good publication practices and associated guidelines set forth by the COPE (Committee on Publication Ethics) (https://publicationethics.org/core-practices).

More information about the Creative Commons Attribution 4.0 International License can be found in the webpage of Creative Commons (CC) by following the link provided below:  https://creativecommons.org/licenses/by/4.0/